First Report of Tar Spot on Orange Geiger, Cordia sebestena, Caused by Diatractium cordianum in Florida.
In July 2007, tar spot symptoms observed on citrus leaves Geiger, sebestena Cordia L. (boraginaceae), in the landscape and commercial nursery in Homestead, FL. This disease appears to be spreading and locally severe. Symptoms are circular, little spots hypertrophy of about 5 to 8 cm in diameter, slightly chlorotic on abaxial surface and has a lot of stromal blackened circular, 0.2-0.4 mm, on the lower surface of leaves. Old and yellowing leaves, the area around the fixed point of pale green.
Embedded in the stroma much Perithecia, 173-312 m diameter, circular to irregular in shape, with a neck that as many as 200 pM lateral length and 73-104 m in diameter. ASCI, 77-92 × 11 to 13 um, are elongated, two-celled ascospores, 50-61 × 3 to 5 um which have narrowing of the striking wall dividing cells. Dimensions and appearance of pathogens fits tightly with those published for Diatractium cordianum (Ellis & Kelsey) Syd (1). Young, asymptomatic C. sebestena leaves were sprayed to runoff with ascospores suspension of approximately 104 ml-1 were harvested from the affected leaves. inoculated leaves were placed on a paper towel saturated with water in petri dishes and kept in a growth chamber at 25 ° C with fluorescent light at 10 h day-1.
Symptoms similar to those observed in the affected trees in the landscape began to evolve after 21 days and Perithecia clear after 28 days. An ITS 1, 2 ITS and 5.8S rDNA sequences deposited in GenBank (Accession No. EU541488). A herbarium specimens deposited in the US National Fungus Collections (BPI No. 878 441). It is a new host record for D. cordianum and is the first time the pathogens have been reported in the United States. previous record comes from Venezuela and several Caribbean islands, including Cuba and Jamaica.
Symptoms of this disease has not been observed in Texas wild olive, Cordia boissieri, near exposed C. sebestena. P. F. Cannon (1) suggests that the disease has no economic impact. However, the striking nature of the C sebestena symptoms and the importance of this tree in South Florida ornamental trade (2) shows that this disease can be significant in the last host. References: (1) P. F. Cannon. Mycol. Res. 92: 327, 1989. (2) D. E. F. G. Gilman and Watson
Randomized, controlled clinical pilot study of venous leg ulcers treated with two types of shockwave therapy.
Background. Venous leg ulcers difficult to heal wounds. The basis of their physiotherapeutic treatment is compression therapy. However, over the years, looking for additional or other methods to supplement the treatment of venous ulcers, which would shorten the duration of treatment, are ongoing. One such method is shockwave therapy.
Method. The aim of our study was to compare radial shockwave therapy (R-ESWT) with a focused shockwave therapy (F-ESWT) in the treatment of venous leg ulcers. Patients were randomly assigned to a group of trees. In the first group of radial shockwave therapy (0.17mJ / mm2, 100 impulses / cm2, 5 Hz), the second group focused shockwave therapy (0.173mJ / mm2, 100 impulses / cm2, 5 Hz) is used and in the third group used a standard treatment. Patients in the shockwave therapy group were given 6 treatments at intervals of five days.
Total area, circumference, Gilman index, maximum length and maximum width of the ulcer was measured. The third group of patients with wet gauze dressing with salt and gently compressing the elastic bandage used (SWC standard wound care).
BID |
|||
ant-353 | ProSpec Tany | 5µg | EUR 60 |
Description: Mouse Anti Human BH3 Interacting Domain Death Agonist |
BID |
|||
CSB-CL002698HU1 | Cusabio | 10 μg plasmid + 200μl Glycerol | Ask for price |
BID |
|||
CSB-CL002698HU2 | Cusabio | 10 μg plasmid + 200μl Glycerol | Ask for price |
Bid |
|||
E8ET1703-92 | EnoGene | 100ul | EUR 275 |
Description: Available in various conjugation types. |
Bid |
|||
MBS8534494-01mL | MyBiosource | 0.1mL | EUR 345 |
Bid |
|||
MBS8534494-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 565 |
Bid |
|||
MBS8534494-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 565 |
Bid |
|||
MBS8534494-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 565 |
Bid |
|||
MBS8534494-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 565 |
BID |
|||
pro-627 | ProSpec Tany | 2µg | EUR 60 |
Description: Recombinant Human BH3 Interacting Domain Death Agonist |
Bid BH3 |
|||
5-00760 | CHI Scientific | 4 x 1mg | EUR 120.12 |
Description: Arg-Asn-Ile-Ala-Arg-His-Leu-Ala-Gln-Val-Gly-Asp-Ser-Met-Asp-Arg |
Bid BH3 |
|||
MBS8246224-10mg | MyBiosource | 10mg | EUR 715 |
Bid BH3 |
|||
MBS8246224-1mg | MyBiosource | 1mg | EUR 260 |
Bid BH3 |
|||
MBS8246224-5mg | MyBiosource | 5mg | EUR 510 |
Bid BH3 |
|||
MBS8246224-5x10mg | MyBiosource | 5x10mg | EUR 3140 |
BID Peptide |
|||
45-021P | ProSci | 0.1 mg | EUR 405.6 |
Description: (CT) BID Peptide |
BID protein |
|||
30R-1173 | Fitzgerald | 100 ug | EUR 622 |
Description: Purified recombinant Human BID protein |
Bid Peptide |
|||
3353P | ProSci | 0.05 mg | EUR 197.7 |
Description: (CT) Bid peptide |
Bid Peptide |
|||
3355P | ProSci | 0.05 mg | EUR 197.7 |
Description: (IN) Bid peptide |
Bid Peptide |
|||
MBS152911-005mg | MyBiosource | 0.05mg | EUR 175 |
Bid Peptide |
|||
MBS152911-5x005mg | MyBiosource | 5x0.05mg | EUR 770 |
Bid Peptide |
|||
MBS151779-005mg | MyBiosource | 0.05mg | EUR 175 |
Bid Peptide |
|||
MBS151779-5x005mg | MyBiosource | 5x0.05mg | EUR 770 |
pcDNA3.1-BID |
|||
PPL00401-2a | Bioworld Biotech | 588bp | EUR 218 |
Description: pcDNA3.1(+) |
BID antibody |
|||
10R-10974 | Fitzgerald | 100 ug | EUR 344 |
Description: Mouse monoclonal BID antibody |
BID antibody |
|||
10R-1121 | Fitzgerald | 100 ul | EUR 320 |
Description: Mouse monoclonal BID antibody |
Bid antibody |
|||
10R-8490 | Fitzgerald | 100 ul | EUR 471.6 |
Description: Mouse monoclonal Bid antibody |
Bid antibody |
|||
10R-8491 | Fitzgerald | 100 ul | EUR 471.6 |
Description: Mouse monoclonal Bid antibody |
Bid Antibody |
|||
24251 | SAB | 100ul | EUR 479 |
Bid Antibody |
|||
24251-100ul | SAB | 100ul | EUR 468 |
Bid Antibody |
|||
24252 | SAB | 100ul | EUR 479 |
Bid Antibody |
|||
24252-100ul | SAB | 100ul | EUR 468 |
Bid antibody |
|||
20R-1486 | Fitzgerald | 100 ug | EUR 807.6 |
Description: Rabbit polyclonal Bid antibody |
Bid antibody |
|||
20R-2964 | Fitzgerald | 100 ul | EUR 471.6 |
Description: Rabbit polyclonal Bid antibody |
BID Antibody |
|||
MBS7121564-005mg | MyBiosource | 0.05mg | EUR 150 |
BID Antibody |
|||
MBS7121564-01mg | MyBiosource | 0.1mg | EUR 190 |
BID Antibody |
|||
MBS7121564-5x01mg | MyBiosource | 5x0.1mg | EUR 845 |
BID Antibody |
|||
MBS7121817-005mg | MyBiosource | 0.05mg | EUR 150 |
BID Antibody |
|||
MBS7121817-01mg | MyBiosource | 0.1mg | EUR 190 |
BID Antibody |
|||
MBS7121817-5x01mg | MyBiosource | 5x0.1mg | EUR 845 |
BID Antibody |
|||
MBS7123403-005mL | MyBiosource | 0.05mL | EUR 190 |
BID Antibody |
|||
MBS7123403-01mL | MyBiosource | 0.1mL | EUR 270 |
BID Antibody |
|||
MBS7123403-5x01mL | MyBiosource | 5x0.1mL | EUR 1205 |
BID Antibody |
|||
MBS7123404-005mL | MyBiosource | 0.05mL | EUR 190 |
BID Antibody |
|||
MBS7123404-01mL | MyBiosource | 0.1mL | EUR 270 |
BID Antibody |
|||
MBS7123404-5x01mL | MyBiosource | 5x0.1mL | EUR 1205 |
BID antibody |
|||
70R-31114 | Fitzgerald | 100 ug | EUR 294 |
Description: Rabbit polyclonal BID antibody |
BID antibody |
|||
70R-31344 | Fitzgerald | 100 ug | EUR 294 |
Description: Rabbit polyclonal BID antibody |
BID Antibody |
|||
E10-30198 | EnoGene | 100μg/100μl | EUR 225 |
Description: Available in various conjugation types. |
BID Antibody |
|||
E19-6016 | EnoGene | 100μg/100μl | EUR 225 |
Description: Available in various conjugation types. |
BID Antibody |
|||
E031037 | EnoGene | 100μg/100μl | EUR 255 |
Description: Available in various conjugation types. |
BID Antibody |
|||
1-CSB-PA787438 | Cusabio |
|
|
Description: A polyclonal antibody against BID. Recognizes BID from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:1000-1:5000, WB:1:200-1:2000, IHC:1:25-1:100 |
BID Antibody |
|||
CAC11767-100ug | Biomatik Corporation | 100ug | EUR 314 |
BID Antibody |
|||
CAC11767-50ug | Biomatik Corporation | 50ug | EUR 199.2 |
BID antibody |
|||
CAF50046-100ug | Biomatik Corporation | 100ug | EUR 312 |
BID Antibody |
|||
1-CSB-PA225375 | Cusabio |
|
|
Description: A polyclonal antibody against BID. Recognizes BID from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:1000-1:5000, WB:1:200-1:2000, IHC:1:25-1:100 |
Bid Antibody |
|||
3272-100 | Biovision | each | EUR 379.2 |
Bid Antibody |
|||
3272-30T | Biovision | each | EUR 175.2 |
Bid Antibody |
|||
49505 | SAB | 100ul | EUR 499 |
Bid Antibody |
|||
49505-100ul | SAB | 100ul | EUR 399.6 |
Bid Antibody |
|||
49505-50ul | SAB | 50ul | EUR 286.8 |
BID antibody |
|||
70R-15995 | Fitzgerald | 50 ul | EUR 289 |
Description: Rabbit polyclonal BID antibody |
Bid antibody |
|||
70R-11670 | Fitzgerald | 100 ug | EUR 343 |
Description: Rabbit polyclonal Bid antibody |
Bid antibody |
|||
70R-11734 | Fitzgerald | 100 ug | EUR 343 |
Description: Rabbit polyclonal Bid antibody |
Bid Antibody |
|||
3172-100 | Biovision | each | EUR 379.2 |
Bid Antibody |
|||
3172-30T | Biovision | each | EUR 175.2 |
BID Antibody |
|||
32014 | SAB | 100ul | EUR 439 |
BID Antibody |
|||
32014-100ul | SAB | 100ul | EUR 302.4 |
BID Antibody |
|||
31037 | SAB | 100ul | EUR 319 |
BID Antibody |
|||
31037-100ul | SAB | 100ul | EUR 302.4 |
BID Antibody |
|||
31037-50ul | SAB | 50ul | EUR 224.4 |
Bid Antibody |
|||
3353-002mg | ProSci | 0.02 mg | EUR 206.18 |
Description: Bid Antibody: Apoptosis plays a major role in normal organism development, tissue homeostasis, and removal of damaged cells. Disruption of this process has been implicated in a variety of diseases such as cancer. The Bcl-2 family of proteins is comprised of critical regulators of apoptosis that can be divided into two classes: those that inhibit apoptosis and those that promote cell death. Bid, a pro-apoptotic Bcl-2 family member, is cleaved by caspase-8 in response to apoptotic signals, exposing the Bcl-2 homology 3 (BH3) domain which is normally buried in the full-length protein. The cleaved complex is myris-toylated and translocated to the mitochondrial membrane where it may induce mitochondrial Bax and Bak to oligomerize. |
Bid Antibody |
|||
3353-01mg | ProSci | 0.1 mg | EUR 523.7 |
Description: Bid Antibody: Apoptosis plays a major role in normal organism development, tissue homeostasis, and removal of damaged cells. Disruption of this process has been implicated in a variety of diseases such as cancer. The Bcl-2 family of proteins is comprised of critical regulators of apoptosis that can be divided into two classes: those that inhibit apoptosis and those that promote cell death. Bid, a pro-apoptotic Bcl-2 family member, is cleaved by caspase-8 in response to apoptotic signals, exposing the Bcl-2 homology 3 (BH3) domain which is normally buried in the full-length protein. The cleaved complex is myris-toylated and translocated to the mitochondrial membrane where it may induce mitochondrial Bax and Bak to oligomerize. |
Bid Antibody |
|||
3355-002mg | ProSci | 0.02 mg | EUR 206.18 |
Description: Bid Antibody: Apoptosis plays a major role in normal organism development, tissue homeostasis, and removal of damaged cells. Disruption of this process has been implicated in a variety of diseases such as cancer. The Bcl-2 family of proteins is comprised of critical regulators of apoptosis that can be divided into two classes: those that inhibit apoptosis and those that promote cell death. Bid, a pro-apoptotic Bcl-2 family member, is cleaved by caspase-8 in response to apoptotic signals, exposing the Bcl-2 homology 3 (BH3) domain which is normally buried in the full-length protein. The cleaved complex is myris-toylated and translocated to the mitochondrial membrane where it may induce mitochondrial Bax and Bak to oligomerize. |
Bid Antibody |
|||
3355-01mg | ProSci | 0.1 mg | EUR 523.7 |
Description: Bid Antibody: Apoptosis plays a major role in normal organism development, tissue homeostasis, and removal of damaged cells. Disruption of this process has been implicated in a variety of diseases such as cancer. The Bcl-2 family of proteins is comprised of critical regulators of apoptosis that can be divided into two classes: those that inhibit apoptosis and those that promote cell death. Bid, a pro-apoptotic Bcl-2 family member, is cleaved by caspase-8 in response to apoptotic signals, exposing the Bcl-2 homology 3 (BH3) domain which is normally buried in the full-length protein. The cleaved complex is myris-toylated and translocated to the mitochondrial membrane where it may induce mitochondrial Bax and Bak to oligomerize. |
BID Antibody |
|||
ABD6016 | Lifescience Market | 100 ug | EUR 525.6 |
BID Antibody |
|||
BF0373 | Affbiotech | 200ul | EUR 540 |
BID Antibody |
|||
BF0373-100ul | Affinity Biosciences | 100ul | EUR 210 |
Description: WB,IHC,IF/ICC,ELISA,FACS |
BID Antibody |
|||
BF0373-200ul | Affinity Biosciences | 200ul | EUR 270 |
Description: WB,IHC,IF/ICC,ELISA,FACS |
BID Antibody |
|||
BF0373-50ul | Affinity Biosciences | 50ul | EUR 150 |
Description: WB,IHC,IF/ICC,ELISA,FACS |
BID Antibody |
|||
B0461-100ul | Assay Biotech | 100μl | EUR 217 |
Description: BID Rabbit Polyclonal Antibody |
BID Antibody |
|||
B0461-50ul | Assay Biotech | 50μl | EUR 143.5 |
Description: BID Rabbit Polyclonal Antibody |
BID Antibody |
|||
AF6879 | Affbiotech | 100ul | EUR 420 |
BID Antibody |
|||
AF6879-100ul | Affinity Biosciences | 100ul | EUR 168 |
Description: WB,ELISA(peptide) |
BID Antibody |
|||
AF6879-200ul | Affinity Biosciences | 200ul | EUR 210 |
Description: WB,ELISA(peptide) |
BID Antibody |
|||
DF6016 | Affbiotech | 200ul | EUR 420 |
BID Antibody |
|||
DF6016-100ul | Affinity Biosciences | 100ul | EUR 168 |
Description: WB,IHC,IF/ICC,ELISA(peptide) |
BID Antibody |
|||
DF6016-200ul | Affinity Biosciences | 200ul | EUR 210 |
Description: WB,IHC,IF/ICC,ELISA(peptide) |
BID Antibody |
|||
1-CSB-PA002698GA01HU | Cusabio |
|
|
Description: A polyclonal antibody against BID. Recognizes BID from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC |
BID Antibody |
|||
1-CSB-PA002698HA01HU | Cusabio |
|
|
Description: A polyclonal antibody against BID. Recognizes BID from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:1000-1:2000 |
BID Antibody |
|||
1-CSB-PA000015 | Cusabio |
|
|
Description: A polyclonal antibody against BID. Recognizes BID from Human. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/10000 |
BID Antibody |
|||
1-CSB-PA000994 | Cusabio |
|
|
Description: A polyclonal antibody against BID. Recognizes BID from Human, Mouse. This antibody is Unconjugated. Tested in the following application: WB, IHC, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.ELISA:1/10000 |
Bid Antibody |
|||
GWB-475F99 | GenWay Biotech | 0.05 mg | Ask for price |
Bid Antibody |
|||
GWB-B8D1C3 | GenWay Biotech | 0.05 mg | Ask for price |
BID Antibody |
|||
GWB-MW143H | GenWay Biotech | 50ug | Ask for price |
Bid Antibody |
|||
E90017 | EnoGene | 100ul | EUR 225 |
Description: Available in various conjugation types. |
BID Antibody |
|||
E90210 | EnoGene | 100ul | EUR 255 |
Description: Available in various conjugation types. |
BID antibody |
|||
E314605 | EnoGene | 200ul | EUR 275 |
Description: Available in various conjugation types. |
BID Antibody |
|||
E38PA4351 | EnoGene | 100ul | EUR 225 |
Description: Available in various conjugation types. |
BID Antibody |
|||
E45M22188G-1 | EnoGene | 100 ul | EUR 395 |
BID Antibody |
|||
E45M22188G-4 | EnoGene | 50 ul | EUR 295 |
BID Antibody |
|||
MBS2518634-006mL | MyBiosource | 0.06mL | EUR 190 |
BID Antibody |
|||
MBS2518634-012mL | MyBiosource | 0.12mL | EUR 265 |
BID Antibody |
|||
MBS2518634-02mL | MyBiosource | 0.2mL | EUR 415 |
BID Antibody |
|||
MBS2518634-5x02mL | MyBiosource | 5x0.2mL | EUR 1835 |
BID antibody |
|||
MBS200123-005mL | MyBiosource | 0.05mL | EUR 260 |
BID antibody |
|||
MBS200123-01mL | MyBiosource | 0.1mL | EUR 345 |
BID antibody |
|||
MBS200123-5x01mL | MyBiosource | 5x0.1mL | EUR 1300 |
Bid Antibody |
|||
MBS150537-01mg | MyBiosource | 0.1mg | EUR 445 |
Bid Antibody |
|||
MBS150537-5x01mg | MyBiosource | 5x0.1mg | EUR 1965 |
Bid Antibody |
|||
MBS151406-01mg | MyBiosource | 0.1mg | EUR 445 |
Bid Antibody |
|||
MBS151406-5x01mg | MyBiosource | 5x0.1mg | EUR 1965 |
Bid Antibody |
|||
MBS5311204-01mg | MyBiosource | 0.1mg | EUR 470 |
Bid Antibody |
|||
MBS5311204-5x01mg | MyBiosource | 5x0.1mg | EUR 2080 |
Bid Antibody |
|||
MBS5311244-01mg | MyBiosource | 0.1mg | EUR 470 |
Bid Antibody |
|||
MBS5311244-5x01mg | MyBiosource | 5x0.1mg | EUR 2080 |
BID Antibody |
|||
MBS8515933-01mg | MyBiosource | 0.1mg | EUR 305 |
BID Antibody |
|||
MBS8515933-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 465 |
BID Antibody |
|||
MBS8515933-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 465 |
BID Antibody |
|||
MBS8515933-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 465 |
BID Antibody |
|||
MBS8515933-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 465 |
BID Antibody |
|||
MBS850664-01mg | MyBiosource | 0.1mg | EUR 305 |
BID Antibody |
|||
MBS850664-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 565 |
BID Antibody |
|||
MBS850664-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 565 |
BID Antibody |
|||
MBS850664-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 565 |
BID Antibody |
|||
MBS850664-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 565 |
Bid Antibody |
|||
MBS8502374-01mg | MyBiosource | 0.1mg | EUR 305 |
Bid Antibody |
|||
MBS8502374-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 565 |
Bid Antibody |
|||
MBS8502374-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 565 |
Bid Antibody |
|||
MBS8502374-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 565 |
Bid Antibody |
|||
MBS8502374-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 565 |
BID Antibody |
|||
MBS8501408-01mL | MyBiosource | 0.1mL | EUR 325 |
BID Antibody |
|||
MBS8501408-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 565 |
BID Antibody |
|||
MBS8501408-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 565 |
BID Antibody |
|||
MBS8501408-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 565 |
BID Antibody |
|||
MBS8501408-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 565 |
Bid Antibody |
|||
MBS9402388-01mL | MyBiosource | 0.1mL | EUR 495 |
Bid Antibody |
|||
MBS9402388-5x01mL | MyBiosource | 5x0.1mL | EUR 2075 |
BID Antibody |
|||
MBS9402484-01mL | MyBiosource | 0.1mL | EUR 305 |
BID Antibody |
|||
MBS9402484-5x01mL | MyBiosource | 5x0.1mL | EUR 1230 |
BID Antibody |
|||
MBS9403310-005mL | MyBiosource | 0.05mL | EUR 300 |
BID Antibody |
|||
MBS9403310-01mL | MyBiosource | 0.1mL | EUR 390 |
BID Antibody |
|||
MBS9403310-5x01mL | MyBiosource | 5x0.1mL | EUR 1610 |
Results. Analysis of the results showed that a complete cure ulcer was achieved in 35% of patients treated with radial shockwave, 26% of patients with focused shock waves used